Related Experiment Video
Updated: Oct 5, 2025

07:56
Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells
Published on: November 16, 2018
6.9K
FGFR2 accommodates osteogenic cell fate determination in human mesenchymal stem cells
Ying Zhang1, Ling Ling2, Arya Ajay D/O Ajayakumar1
1Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 138673, Singapore.
Gene
|January 30, 2022
Summary
Fibroblast growth factor receptor 2 (FGFR2) is crucial for human mesenchymal stem cell (hMSC) osteogenic differentiation. Reduced FGFR2 impairs bone formation and promotes fat cell development, impacting hMSC multipotency.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Molecular biology
Background:
- Human mesenchymal stem cells (hMSCs) possess multilineage differentiation potential vital for tissue regeneration.
- Growth factors and their receptors, like fibroblast growth factors (FGFs) and FGF receptors (FGFRs), regulate hMSC fate decisions.
- The precise role of FGFRs in orchestrating osteogenic progression requires further elucidation.
Purpose of the Study:
- To investigate the role of FGFRs in osteogenic differentiation of hMSCs.
- To determine the correlation between FGFR expression levels and osteogenic markers.
- To elucidate the molecular mechanisms by which FGFRs influence hMSC lineage commitment.
Main Methods:
- Studied FGFR protein levels during osteogenesis in human adult bone marrow-derived MSCs.
- Utilized RNA interference (RNAi) to knock down FGFR2 expression.
- Analyzed gene expression profiles for osteogenic and adipogenic markers.
- Assessed the expression of Enhancer of Zeste Homolog 2 (EZH2) following FGFR2 knockdown.
- Evaluated osteogenic potential in serially passaged hMSCs.
Main Results:
- A positive correlation was observed between FGFR2 expression and alkaline phosphatase (ALP) activity, an early osteogenic marker.
- FGFR2 knockdown significantly downregulated pro-osteogenic genes and upregulated pro-adipogenic genes, indicating a shift towards adipogenic commitment.
- FGFR2 knockdown led to increased EZH2 expression under osteogenic induction conditions.
- Serial passaging of hMSCs resulted in reduced FGFR2 expression and diminished osteogenic potential.
Conclusions:
- FGFR2 plays a critical role in mediating osteogenic fate in hMSCs.
- FGFR2 regulates the balance between osteogenic and adipogenic lineage commitment.
- Reduced FGFR2 expression in passaged hMSCs contributes to impaired osteogenic capacity.
- Monitoring FGFR2 levels may serve as a useful indicator of hMSC multipotency during serial passaging.
Related Concept Videos
Mesenchymal Stem Cells
5.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
Master Transcription Regulators
7.2K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
TGF - β Signaling Pathway
7.9K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
Determination
19.5K
During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In...
19.5K

